RXRX   $3.83  -4.96% Market Closed After Close 3.84 0.26%

Recursion Pharmaceuticals, Inc.
Total Cash 474.34M
totalCashPerShare 1.688
EBITDA -364.95M
Total Debt 89.88M
quickRatio 5.54
currentRatio 6.068
Total Revenue 49.63M
debtToEquity 15.378
Revenue/Share 0.218
ROA -0.34351003
ROE -0.71182996
grossProfits
freeCashflow -226.71M
operatingCashflow -331.52M
earningsGrowth
revenueGrowth 0.309
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -6.9739203
profitMargins 0.0
enterpriseValue 1.57B
forwardPE -3.9157302
floatShares 246.43M
sharesOutstanding 284.19M
sharesShort 59.44M
sharesShortPriorMonth 59.16M
dateShortInterest
sharesPercentSharesOut 0.20%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.92%
Short Ratio help_outline 11.89%
shortPercentOfFloat 0.23%
impliedSharesOutstanding
bookValue 2.08
Price To Book help_outline 3.35
earningsQuarterlyGrowth
netIncomeToCommon -374.93M
trailingEps -1.70%
forwardEps -1.78%
enterpriseToEbitda -4.31
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.35 3Q 2024
institutionsCount 362
lastUpdated Nov. 7, 2024, 5 a.m.